Probiotics for Prophylaxis of Postoperative Hirschsprungs Associated Enterocolitis
NCT ID: NCT02343562
Last Updated: 2018-01-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
40 participants
INTERVENTIONAL
2014-10-31
2018-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Probiotics and Post-Pullthrough Hirschsprung's Disease-Associated Enterocolitis
NCT07098494
Probiotic Prophylaxis of Hirschprung's Disease Associated Enterocolitis (HAEC)
NCT00630838
A Trial on Probiotics in Preventing Hirschsprung's Disease Associated Entercolitis
NCT01934959
Assessing the Efficacy of Probiotics in Prevention of NEC in Preterm Babies
NCT07233382
Observational Prospective Study With Probiotic Supplementation on Infants With FGDI
NCT04944628
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Probiotics Group
Will receive Sachet-form probiotics
Probiotics
Probiotics in the form of sachet will be given twice daily for a period of at least 6 months during the trial period.
Placebo Group
Will receive off-the-shelf oral multivitamin
Placebo
Multivitamin off-the-counter.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Probiotics
Probiotics in the form of sachet will be given twice daily for a period of at least 6 months during the trial period.
Placebo
Multivitamin off-the-counter.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
6 Months
12 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cairo University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mahmoud Elfiky, MD
Lecturer of Pediatric Surgery
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mahmoud MA Elfiky, M.D.
Role: PRINCIPAL_INVESTIGATOR
Cairo University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cairo University Pediatric Hospital
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
El-Sawaf M, Siddiqui S, Mahmoud M, Drongowski R, Teitelbaum DH. Probiotic prophylaxis after pullthrough for Hirschsprung disease to reduce incidence of enterocolitis: a prospective, randomized, double-blind, placebo-controlled, multicenter trial. J Pediatr Surg. 2013 Jan;48(1):111-7. doi: 10.1016/j.jpedsurg.2012.10.028.
Demehri, Farokh R., et al.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PACTR201408000867421
Identifier Type: OTHER
Identifier Source: secondary_id
CAIUNIPEDSURG-CR1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.